September 15, 2025 | HcSimWeek25, MedSims, Virtual Simulation

Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just access to information—but mastery of critical thinking and real-world medical reasoning. In an era where clinical experience cannot be replaced, award-winning platforms like Medscape’s MedSims offer an immersive, safe, interactive space to refine judgment, build decision-making confidence, and ensure that next-level care is more than just theoretical.
Virtual patient simulation is a popular CME choice for clinicians, with 65% of Medscape members saying they liked or liked it a lot, and 35% citing they used it on a weekly to monthly basis2. As of February 2024, over 1.2 million learners have treated virtual patients with MedSims, collectively making more than 5.5 million treatment decisions. They ordered 8 million tests, made 1.8 million diagnoses, and made 3 million consults, referrals, or non-medication decisions. In addition, the rationales behind more than 2.6 million clinical decisions were captured3.
For the 33 MedSims programs developed since 2022, an average of 221 engaged learners have participated in the outcome assessments. Those programs have shown a pre-assessment average of 40% and post of 68% with a +70% increase in performance across all learning objectives4.
Virtual patient simulation platforms like MedSims are ideal solutions for showcasing real-world clinical practice scenarios and improving differential diagnosis techniques. The MedSims platform captures every decision point and rationale for specific treatment selections, such as dosing, frequency, and administration decisions. MedSims’ safe learning environment enhances physicians’ competence and confidence. The platform is designed to promote effective point-of-care decisions, examine supporting rationales, and improve patient outcomes.
“Virtual patient simulation, which immerses and engages clinicians in an authentic and practical learning experience, can significantly improve decision-making of physicians and ultimately improve patient outcomes,” said Katie Lucero, PhD, Chief Impact Officer at Medscape Education.
In 2020, an independent analysis of 5 MedSims activities by The Calibre Institute for Quality Medical Education gave MedSims VPS a superior instructional design score, noting its “high potential to engage physicians and lead to improvements in clinical practice and outcomes.”5
Evidence of MedSims proven impact is featured in 74 poster publications since 2014 including a win at Best Practice in Learner Outcomes Award from NAMEC (National Association of Medical Education Companies) in 2022 with patients with a type 2 diabetes program. The outcomes study showed that within the study sample of 157 clinicians, 25% of clinicians had more patients with T2D who received a glycemic control treatment indicated for CV risk prevention (GLP-1 RA). Ultimately, those 25% of clinicians represented 7,747 patients with T2D in a 6mos period; 6% more patients with T2D received the benefits of GLP-1 RAs after education in the intervention group. The intervention group was 4 times more likely to use GLP-1 RAs with patients with T2D than the matched comparison group (logistic regression)6.
For more information about Medscape’s Virtual Patient Simulation capabilities please sign up here.
References
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
Follow Medscape Education LinkedIn.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
As the world of medicine continues to evolve, it's crucial to stay ahead of the curve. In this dynamic era, digital communications have emerged as a driving force in discussions...
From September 27-30, members of the Medscape Education Global team were in Athens, Greece sharing 5 posters at the International Myeloma Society Annual Meeting, 2023.The posters presented the outcomes and...
Education on rare diseases is crucial. Estimates suggest there are approximately 10,000 rare diseases, with 263–446 million people affected worldwide.Since its launch in September 2022, the Medscape Pathways in Rare...
An analysis of data using Real-World Outcomes showed that a virtual patient simulation had a significant effect on real-world treatment selection for T2D. The paper, published in JMIR Medical Education,...
A Novel Provider Education Module to Enhance Detection of Alpha-1 Antitrypsin Deficiency
ERS 2023 will mark the new release of outcomes data by Medscape Education Global. During the poster hall sessions on September 12, the Medscape team will present a poster that...
Education Supported by the National Highway Traffic Safety Administration
Medscape Education Global is joining cardiology professionals from across Europe for ESC 2023 in Amsterdam. This year’s congress theme is “Joining Forces to Protect the Heart,” and Medscape will be...
The Pathways in Rare Disease Learning Center celebrates a momentous achievement - engaging one million learners in its educational initiatives. This milestone signifies a profound impact on clinician confidence in...
At Medscape Education, we hold ourselves to the highest standards when it comes to analysing our programs. Our approach is unparalleled, employing a precise paired method that ensures we measure the...
